Loading clinical trials...
Loading clinical trials...
Identification of Molecular and Epidemiological Risk Factors in the Development of Gastric Cancer in High-risk Predominantly Hispanic Population
Conditions
Interventions
Molecular testing for all participants.
Germline Testing
+1 more
Locations
1
United States
Mays Cancer Center, UT Health San Antonio
San Antonio, Texas, United States
Start Date
January 22, 2021
Primary Completion Date
January 22, 2030
Completion Date
January 22, 2030
Last Updated
March 18, 2025
NCT04704661
NCT04550494
NCT05489211
NCT04674267
NCT05702229
NCT07217704
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions